SeekingAlpha · Aug 12, 2026
Demant A/S (WILYY) Q2 2026 Earnings Call Transcript
Demant A/S (WILYY) Q2 2026 Earnings Call August 12, 2026 8:00 AM EDTCompany ParticipantsPeter Pudselykke - Head of Investor Relations (Leave of...
OTC · WILYY
Healthcare · Medical - Devices
$23.00
Up+$0.00 (+0.00%)
Updated Aug 18, 2026, 12:41 PM
SID Score
6.0/10
Composite research score
Smart Money
46/100
Neutral
Price performance
1M range · 0 trading sessions · Daily adjusted prices
WILYY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning WILYY.
WILYY research
Company profile and research snapshot.
DEMANT HLDG U/ADR
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 13, 2026 | JYSKE BANK | Buy | — |
| Jul 8, 2026 | ROTHSCHILD & CO REDBURN | Buy | — |
| Jun 22, 2026 | JEFFERIES | Buy | — |
| Jun 17, 2026 | DNB CARNEGIE | Buy | — |
| Jun 7, 2026 | BAADER EUROPE / ALPHAVALUE | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Aug 12, 2026
Demant A/S (WILYY) Q2 2026 Earnings Call August 12, 2026 8:00 AM EDTCompany ParticipantsPeter Pudselykke - Head of Investor Relations (Leave of...
SeekingAlpha · Feb 4, 2026
SeekingAlpha · Feb 3, 2026
Demant A/S (WILYY) Q4 2025 Earnings Call February 3, 2026 8:00 AM ESTCompany ParticipantsPeter Pudselykke - Head of Investor Relations (Leave of...
GlobeNewswire Inc. · Jan 29, 2025
The global cochlear implants market is expected to grow significantly, driven by the increasing prevalence of hearing loss, advancements in implant technology, and supportive government initiatives. Key players are investing in research and awareness campaigns to expand accessibility and improve patient outcomes.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning WILYY.